<code id='0AB8B8EFB5'></code><style id='0AB8B8EFB5'></style>
    • <acronym id='0AB8B8EFB5'></acronym>
      <center id='0AB8B8EFB5'><center id='0AB8B8EFB5'><tfoot id='0AB8B8EFB5'></tfoot></center><abbr id='0AB8B8EFB5'><dir id='0AB8B8EFB5'><tfoot id='0AB8B8EFB5'></tfoot><noframes id='0AB8B8EFB5'>

    • <optgroup id='0AB8B8EFB5'><strike id='0AB8B8EFB5'><sup id='0AB8B8EFB5'></sup></strike><code id='0AB8B8EFB5'></code></optgroup>
        1. <b id='0AB8B8EFB5'><label id='0AB8B8EFB5'><select id='0AB8B8EFB5'><dt id='0AB8B8EFB5'><span id='0AB8B8EFB5'></span></dt></select></label></b><u id='0AB8B8EFB5'></u>
          <i id='0AB8B8EFB5'><strike id='0AB8B8EFB5'><tt id='0AB8B8EFB5'><pre id='0AB8B8EFB5'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:knowledge    Page View:7325
          the U.S. Medicare Handbook is photographed in Washington.
          Pablo Martinez Monsivais/AP

          Roughly 33.4 million adults older than 65 and people with disabilities were enrolled in a Medicare Advantage plan as the calendar flipped to 2024 — another year of steady, albeit slower, growth for the taxpayer-funded program.

          Enrollment increased 7.1% year over year, which would make this year’s annual growth rate identical to last year’s, according to new federal Medicare Advantage enrollment data analyzed by STAT.

          advertisement

          The data reinforce how America’s Medicare program continues to shift toward a more privatized version that has not saved any money for taxpayers, has been linked to inappropriate coding practices, and has restricted care for older and vulnerable patients. And even though the federal government made several changes to Medicare Advantage for 2024 — changes that were vehemently opposed by the health insurance industry — the program’s growth has not been stunted, nor did insurers dramatically slash their offerings.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more
          NIH chief: government has fallen behind pharma on clinical trials
          NIH chief: government has fallen behind pharma on clinical trials

          NationalInstitutesofHealthDirectorMonicaBertagnollitestifiesduringherSenateHELPCommitteeconfirmation

          read more
          Anesthesiologist group: stop taking Ozempic before surgery
          Anesthesiologist group: stop taking Ozempic before surgery

          EspeciallyinthefirstweeksoftakingdrugslikeOzempic,foodstayslongerinthestomach—aprobleminsurgeries.Ad

          read more

          PhRMA lawsuit over Medicare drug price negotiation tossed

          APStockWASHINGTON—AfederaldistrictjudgeonMondaygrantedtheBidenadministration’srequesttodismissalawsu